Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H<sub>2</sub>O<sub>2</sub>-Induced Cardiomyocyte Injury.
Ontology highlight
ABSTRACT: The identification of exogenous ligands from natural products is an alternative strategy to explore the unrevealed physiological functions of orphan G-protein-coupled receptors (GPCRs). In this study, we have successfully identified and pharmacologically characterized licoisoflavone A (LIA) as a novel selective antagonist of BRS-3, an orphan GPCR. Functional studies showed that pretreatment with LIA ameliorated hydrogen peroxide (H2O2)-induced cardiomyocyte injury. Furthermore, LIA pretreatment significantly restored the activities of malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT), as well as lactate dehydrogenase (LDH) levels, in H9c2 cells following H2O2 exposure. The protective effect of LIA was also evident in primary c
SUBMITTER: Lu J
PROVIDER: S-EPMC11943355 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA